Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Jamoul
C. Jamoul
Pathology
Cancer
Medicine
Randomized controlled trial
Adjuvant therapy
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DERMA phase III trial of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in patients with MAGE-A3-positive resected stage III melanoma.
2011
Journal of Clinical Oncology
J. M. Kirkwood
B. Dreno
A. Hauschild
D. Schadendorf
Alessandro Testori
Peter Hersey
C. Jamoul
O Peeters
Patrick Therasse
Show All
Source
Cite
Save
Citations (12)
PREDICT phase II: A trial to prospectively validate a gene signature associated with clinical benefit from MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) in patients with unresected metastatic cutaneous melanoma.
2011
Journal of Clinical Oncology
P. Saiag
Jeffrey S. Weber
B. Dreno
A. Hauschild
C. Jamoul
O Peeters
Patrick Therasse
Show All
Source
Cite
Save
Citations (0)
1